Search

Your search keyword '"Wang-Gohrke S."' showing total 339 results

Search Constraints

Start Over You searched for: Author "Wang-Gohrke S." Remove constraint Author: "Wang-Gohrke S."
339 results on '"Wang-Gohrke S."'

Search Results

1. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

2. Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

3. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk

4. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: A combined case-control study

5. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".

6. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

7. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

8. Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.

10. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

11. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

12. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

13. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

14. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

15. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

16. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

17. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

18. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

19. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

20. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

21. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

22. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

24. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

25. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

26. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

27. Risk of Ovarian Cancer and the NF-? B Pathway: Genetic Association with IL1A and TNFSF10

28. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

29. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

30. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

31. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

32. BRCA1/2-Mutationsprävalenz bei Patientinnen mit Triple-negativem Mammakarzinom und ohne familiäre Belastung für Brust- und Eierstockkrebs

33. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

34. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

35. Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

36. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

37. Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

38. Refined histopathological predictors of BRCA1\ud and BRCA2 mutation status: a large-scale analysis\ud of breast cancer characteristics from the BCAC,\ud CIMBA, and ENIGMA consortia

39. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

40. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

41. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

42. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

43. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

44. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

45. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

46. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

47. Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors

48. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

49. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

50. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

Catalog

Books, media, physical & digital resources